OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer

SAN DIEGO and NEW JERSEY, Oct. 29, 2018 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the appointment of Kellie Malloy Foerter ... Biopharmaceuticals, Oncology, Personnel OncoSec Medical, intratumoral immunotherapies, tavokinogene, telseplasmid
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news